Long-Term Risk of Colorectal Cancer in Patients With Prediabetes: A Comprehensive Systematic Review and Meta-Analysis

Authors

  • Praneeth Reddy Keesari Department of Internal Medicine, Staten Island University Hospital, Staten Island, New York, USA
  • Akhil Jain Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Yashwitha Sai Pulakurthi Department of Internal Medicine, New York Medical College - Saint Michael‘s Medical Center, Newark, NJ, USA
  • Rewanth R. Katamreddy Department of Internal Medicine, New York Medical College - Saint Michael‘s Medical Center, Newark, NJ, USA
  • Ali Tariq Alvi Department of Internal Medicine, HCA Florida, Westside Hospital, Plantation, Florida, USA
  • Rupak Desai Independent Researcher, Atlanta, GA, USA

DOI:

https://doi.org/10.15403/jgld-5527

Keywords:

prediabetes, hyperglycemia, colon cancer, colorectal cancer, meta-analysis, long-term

Abstract

Background and Aims: Prediabetes is often underdiagnosed and underreported due to its asymptomatic state in over 80% of individuals. Considering its role in promoting cancer incidence and limited evidence linking prediabetes and colorectal cancer (CRC), we conducted a systematic review and meta-analysis to evaluate the incidence of colorectal cancer in people with prediabetes.

Methods: A comprehensive search through PubMed/Medline, Embase, Scopus, and Google Scholar was performed until June 1, 2022, to screen for studies reporting CRC incidence/risk in prediabetics. Binary random-effects models were used to perform meta-analysis and subgroup analyses. Sensitivity analysis was done using leave-one-out method. The quality of the studies was assessed by the Newcastle Ottawa Scale for observational studies.

Results: Seven prospective and one retrospective study comprising 15 cohorts and a pooled number of 854,876 cases and 219,0511 controls were included in the analysis (2 Japan, 2 Korea, 1 Sweden, 1 UK, 1 China, and 1 USA). After combining all the studies, the forest plots for adjusted analysis shows a statistically significant increase in odds of having CRC with prediabetes (OR=1.16; 1.08–1.25, p< 0.01; I2=56.06%) and unadjusted analysis also shows a statistically significant increase in odds of having CRC with prediabetes (OR=1.62; 1.35–1.95, p< 0.01; I2=85.72% ). Sensitivity analysis using the Leave-one-out method did confirm equivalent results. Subgroup analysis based on type of study, the odds of developing CRC was higher in prospective studies (OR=1.175; 1.065-1.298) (p=0.001) than retrospective studies (OR=1.162; 1.033- 1.306) (p=0.012). The odds of developing CRC were not significantly higher in ages >60 (OR=1.446; 0.887-2.356) (p=0.139) compared to less than 60 years. The strongest association b/w prediabetes and CRC was found on a median 5-10 years (aOR=1.257; 1.029-1.534) (p=0.025) follow-up compared to < 5 years and 10 years and higher.

Conclusions: This study showed that the odds of developing CRC is 16% higher in patients with prediabetes than those with normal blood glucose. Lifestyle modifications such as weight loss, proper diet, and exercise are essential to control prediabetes. This study further warrants a specific prediabetes screening for patients already at high risk of colorectal cancer with other risk factors.

Published

2024-09-29

How to Cite

1.
Keesari PR, Jain A, Pulakurthi YS, Katamreddy RR, Alvi AT, Desai R. Long-Term Risk of Colorectal Cancer in Patients With Prediabetes: A Comprehensive Systematic Review and Meta-Analysis. JGLD [Internet]. 2024 Sep. 29 [cited 2026 Jul. 22];33(3):386-93. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/5527

Issue

Section

Systematic Review and Meta-Analysis